Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza versus pregabalin in peripheral neuropathic pain
2011-005872-41Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Peripheral neuropathic pain, postherpetic neuralgia (PHN) and Non-diabetic Peripheral Polyneuropathy comparing Qutenza arm with Pregabalin arm (2 arms). Primary endpoint: Proportion of subjects with ≥30% reduction in average pain at 8 weeks. Started Mar 2012; status: completed.
02
Drugs
capsaicinpregabalin
03
Conditions
Peripheral neuropathic painpostherpetic neuralgia (PHN)Non-diabetic Peripheral Polyneuropathy
Beyond the preview
Go deeper on 2011-005872-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005872-41.